New cell wall targets for antifungal drugs

Area of Science:

• Medical Mycology
• Biochemistry
• Drug Discovery

Background:

• Fungal infections, especially invasive aspergillosis, pose significant threats to immunocompromised individuals.
• Current antifungal treatments face challenges, necessitating the development of novel therapeutic options.
• The fungal cell wall, a structure absent in human cells, presents a promising target for antifungal drug development.

Purpose of the Study:

• To identify new therapeutic targets for invasive fungal infections.
• To explore novel antifungal strategies distinct from existing treatments.
• To review assays for screening inhibitors of key enzymes in fungal cell wall precursor synthesis.

Main Methods:

• Focus on biochemical pathways synthesizing uridine di-phospho sugars, precursors for fungal cell wall carbohydrates.
• Identification of critical enzymes within these pathways as potential drug targets.
• Discussion of assays designed to screen for inhibitors of these enzymes.

Main Results:

• Several novel therapeutic targets within fungal cell wall precursor synthesis pathways have been identified.
• Enzymes involved in the synthesis of uridine di-phospho sugars are highlighted as promising targets.
• Assays for screening enzyme inhibitors are discussed as a method for drug discovery.

Conclusions:

• Targeting fungal cell wall precursor synthesis offers a promising avenue for developing new antifungals.
• This approach provides a strategy for novel antifungal agents with different mechanisms of action.
• Further research into these pathways and enzyme inhibitors could lead to effective treatments for invasive fungal infections.